JEFFREY B KINDLER
CIK 1174454 · Executive Chairman · last filed 2026-06-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$23.84M
Companies
10
Total Filings
178
Lifetime Open-Market Net
-$1.08M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PRAX | Director | 2,537 | $295.81 | $750.5K | $0 | 2 | 2026-06-12 |
| Terns Pharmaceuticals, Inc. (TERN) Delisted | Director | — | $52.95 | — | $0 | 9 | 2026-05-05 |
| PGEN | Director | 202,100 | $5.53 | $1.12M | -$1.71M | 17 | 2026-03-16 |
| PRGO | Director | 10,559 | $10.30 | $108.8K | -$497.5K | 15 | 2025-05-16 |
| PPD, Inc. (PPD) Delisted | Director | 0 | $47.28 | $0 | $499.5K | 4 | 2021-12-08 |
| VTVT | Executive Chairman | 875 | $31.08 | $27.2K | $0 | 7 | 2020-06-15 |
| SIGA | Director | 127,339 | $3.34 | $425.3K | $0 | 10 | 2020-05-22 |
| PRECIGEN, INC. (XON) Delisted | Director | 84,040 | — | — | $627.7K | 16 | 2019-03-26 |
| CMG | Director | 15,650 | $33.51 | $524.4K | $0 | 2 | 2013-05-17 |
| PFE | Former Chairman & CEO | 827,296 | $25.25 | $20.89M | $0 | 91 | 2010-12-17 |
Recent Filings · Page 2 of 18
178 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-09-30 | PGEN | Notice (144) | −106,837 | -$351.5K | EDGAR |
| 2025-09-29 | PGEN | Notice (144) | −67,523 | -$245.1K | EDGAR |
| 2025-06-12 | Terns Pharmaceuticals, Inc. (TERN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-05-16 | PRGO | Mixed | +5,150 | $134.0K | EDGAR |
| 2025-03-17 | PGEN | Mixed | +127,067 | $69.0K | EDGAR |
| 2025-02-03 | Terns Pharmaceuticals, Inc. (TERN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-12-10 | PRGO | Sell (S) | −17,598 | -$497.5K | EDGAR |
| 2024-12-09 | PRGO | Notice (144) | −17,598 | -$497.4K | EDGAR |
| 2024-07-02 | Terns Pharmaceuticals, Inc. (TERN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-06-14 | Terns Pharmaceuticals, Inc. (TERN) Delisted | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.